Caricamento...
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma
Clear cell sarcoma is an aggressive soft tissue sarcoma and highly resistant to conventional chemotherapy and radiation therapy. This devastating disease is defined by EWSR1‐ATF1 fusion gene resulting from chromosomal translocation t(12;22)(q13;q12) and characterized by melanocytic differentiation....
Salvato in:
| Pubblicato in: | Cancer Med |
|---|---|
| Autori principali: | , , , , , , , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5603837/ https://ncbi.nlm.nih.gov/pubmed/28745431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1130 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|